Skip to Main Content

Advertisement

Skip Nav Destination

Abstract LB070: Development of Claudin 18.2/CD3 bispecific antibody maintaining effector functions for better cancer therapy

Cancer Res (2021) 81 (13_Supplement): LB070.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal